MedPath

ADJUSTment Disorder in Cancer Patients: Effectiveness and Cost-Utility of Tailored Psychological Treatment

Conditions
adjustment disorder
Cancer
10027655
Registration Number
NL-OMON55359
Lead Sponsor
Vrije Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
206
Inclusion Criteria

* age * 18 years;
* diagnosed with cancer (all types and stages, except non-melanoma skin
cancer);
* patients after the end of primary cancer treatment with curative or
palliative intent (all treatment modalities, except for endocrine therapy in
breast/prostate cancer),
* presence of an adjustment disorder as diagnosed with a diagnostic interview.

Exclusion Criteria

Patients who are not able to complete a Dutch questionnaire.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome of this study is psychological distress, as measured using<br /><br>the Hospital Anxiety and Depression Scale.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures of this study are coping, measured using the Mental<br /><br>Adjustment to Cancer Scale, and quality of life as measured using the EORTC<br /><br>QLQ-C30. In addition, the cost-utility of the psychological intervention will<br /><br>be investigated. Costs will be measured using the medical consumption<br /><br>questionnaire (iMCQ) and productivity cost questionnaire (iPCQ). The EQ-5D-5L<br /><br>will be used to measure quality-adjusted life-years. </p><br>
© Copyright 2025. All Rights Reserved by MedPath